Inhibrx Biosciences, Inc. (INBX) Q1 2024 Earnings
INBX·Reported June 3, 2024·Before market open
Diluted EPS came in at $-1.44, missed the $-1.04 consensus by $0.40.
Diluted EPS
$-1.44missed by $0.40
Consensus: $-1.04
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2024 Earnings FAQ
Common questions about Inhibrx Biosciences, Inc.'s Q1 2024 earnings report.
Inhibrx Biosciences, Inc. (INBX) reported Q1 2024 earnings on June 3, 2024 before market open.
Inhibrx Biosciences, Inc. reported diluted EPS of $-1.44 for Q1 2024.
EPS missed the consensus estimate of $-1.04 by $0.40.